Your browser doesn't support javascript.
loading
Prevalence of nonalcoholic fatty liver disease and liver cirrhosis in Chinese adults with type 2 diabetes mellitus.
Han, Xinyu; Zhang, Xin; Liu, Zhenqiu; Fan, Hong; Guo, Chengnan; Wang, Haili; Gu, Yu; Zhang, Tiejun.
Afiliação
  • Han X; Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China.
  • Zhang X; Key Laboratory of Public Health Safety (Fudan University), Ministry of Education, Shanghai, China.
  • Liu Z; Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China.
  • Fan H; Key Laboratory of Public Health Safety (Fudan University), Ministry of Education, Shanghai, China.
  • Guo C; State Key Laboratory of Genetic Engineering, Human Phenome Institute, School of Life Sciences, Fudan University, Shanghai, China.
  • Wang H; Fudan University Taizhou Institute of Health Sciences, Taizhou, China.
  • Gu Y; Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China.
  • Zhang T; Key Laboratory of Public Health Safety (Fudan University), Ministry of Education, Shanghai, China.
J Diabetes ; 16(5): e13564, 2024 May.
Article em En | MEDLINE | ID: mdl-38664879
ABSTRACT

BACKGROUND:

Nonalcoholic fatty liver disease (NAFLD) and liver cirrhosis are significant clinical concerns, especially among individuals with type 2 diabetes mellitus (T2DM). However, in China, there is a paucity of reliable evidence detailing the characteristics of NAFLD and liver cirrhosis in T2DM. Furthermore, the relationship between blood glucose levels and NAFLD prevalence remains unclear.

METHODS:

Data from the Shanghai Suburban Adult Cohort and Biobank were analyzed, including 6621 participants with T2DM. NAFLD was diagnosed by ultrasonography and liver cirrhosis was performed according to the health information systems. Logistic regression and restricted cubic spline analysis were used to explore the potential risk factors for NAFLD and liver cirrhosis.

RESULTS:

The prevalence of NAFLD was 59.36%, and liver cirrhosis was 1.43% among T2DM patients. In these patients, factors like age, being female, marital status, and obesity significantly increased the risk of NAFLD. Specifically, obesity had a strong positive association with NAFLD (odds ratio [OR] = 4.70, 95% confidence interval [CI] 4.13-5.34). The higher glycated hemoglobin (HbA1c) quartile was associated with a heightened NAFLD risk compared to the lowest quartile (all p < .001). The HbA1c-NAFLD relationship displayed a linear that mimicked an inverted L-shaped pattern. A significant positive association existed between HbA1c levels and NAFLD for HbA1c <8.00% (OR = 1.59, 95% CI 1.44-1.75), but this was not observed for HbA1c >8.00% (OR = 1.03, 95% CI 0.92-1.15).

CONCLUSION:

Systematic screening for NAFLD is essential in T2DM patients, especially with poor glucose control and obesity in female.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Hepatopatia Gordurosa não Alcoólica / Cirrose Hepática Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: J Diabetes Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China País de publicação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Hepatopatia Gordurosa não Alcoólica / Cirrose Hepática Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: J Diabetes Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China País de publicação: Austrália